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Src homology 3 domain
Splice varianta b s t r a c t
N2-Src is a poorly understood neuronal splice variant of the ubiquitous C-Src tyrosine kinase,
containing a 17 amino acid insert in its Src homology 3 (SH3) domain. To characterise the properties
of N2-Src we directly compared its SH3 domain speciﬁcity and kinase activity with C- and N1-Src
in vitro. N2- and N1-Src had a similar low afﬁnity for the phosphorylation of substrates containing
canonical C-Src SH3 ligands and synaptophysin, an established neuronal substrate for C-Src. N2-Src
also had a higher basal kinase activity than N1- and C-Src in vitro and in cells, which could be
explained by weakened intramolecular interactions. Therefore, N2-Src is a highly active kinase that
is likely to phosphorylate alternative substrates to C-Src in the brain.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical
Societies. This is an open access article under the CC BY license (http://creativecommons.org/licenses/
by/4.0/).1. Introduction (Fig 1C; [7,9]). Neuronal splicing of C-Src and the charge distribu-The Src family of non-receptor tyrosine kinases (SFK) play
fundamental roles in growth factor receptor and cell adhesion sig-
nalling in diverse processes including proliferation, differentiation,
migration, membrane trafﬁcking and electrical excitability [1]. Of
the 11 SFK members, C-Src, Fyn, Yes, Lck and Lyn are highly
enriched in the mammalian brain and regulate major functions,
including neuronal differentiation, axon guidance, neurotransmit-
ter release and learning and memory [2–5]. C-Src has two splice
variants expressed solely in neuronal tissue [6–8], termed N1-
and N2-Src, which arise from insertions of the mini-exons N1 or
N1 & N2, respectively. N1-Src contains a six amino acid insert in
the n-src loop of its Src homology 3 (SH3) domain, while in
N2-Src, the N1 and N2 mini-exons insert a total of 17 amino acidstion of the N1-Src inserts is conserved from teleost ﬁsh to man
[10–13], while N2-Src is only found in mammals, suggesting it is
important for higher brain functions. However, the regulation
and in vivo substrates of the neuronal Srcs remain largely
unknown.
Due to the critical role played by SH3 domains in substrate
recognition, it was previously predicted that N-Src binding to
known C-Src ligands is altered [14]. Indeed, studies have shown
that interactions between the N1-Src SH3 domain and a number
of neuronal proteins are reduced or abolished compared to C-Src
[15–19]. Although there are several putative N1-Src SH3 domain
binding partners [20–23], none of these interactions have been
conﬁrmed in vivo and only the NMDA (N-methyl D-aspartate)
receptor subunit, NR2A, has been shown to be phosphorylated by
N1-Src (in vitro; [24]). To date, no binding partners or substrates
have been identiﬁed for N2-Src, however, high levels of N2-Src
expression correlate with a good prognosis in the childhood cancer
neuroblastoma [25].
In addition to altered substrate binding, the N1-Src SH3 domain
has been shown to increase its kinase activity in cells above that of
C-Src [8,26,27]. We hypothesise these observations are due to a
reduction in the ability of the N1-Src SH3 domain to form
intramolecular association with the Src homology 2 (SH2):kinase
linker that normally constrains the activity of C-Src [28,29]. In this
Fig. 1. Expression and puriﬁcation of active Src kinases for in vitro kinase assays.
(A) Schematic of the GST-PTP1B-His-D80Src construct (lacking the ﬁrst 80 residues
of rat full length Src) used to express active Src kinases in E. coli. The 3C protease
site to produce His-Src is indicated. (B) Coomassie stained SDS–PAGE gels showing
the stages of a representative expression and puriﬁcation of GST-PTP1B-His-
D80N1-Src (asterisk; left panel) and its cleavage to yield His-D80N1-Src (arrow;
middle panel). The right panel shows a comparison of puriﬁed His-D80C-, N1- and
N2-Srcs (arrow). (C) Schematic showing the principles of an in vitro Src kinase assay
in which GST-peptide substrates contain a tyrosine residue that can be phospho-
rylated by the Src kinase domain, and a proline rich sequence inserted at the
position of PxxP to assess the effect of SH3 domain binding. The primary sequences
of the n-Src loops of the C-, N1- and N2-Src SH3 domains are also depicted. (D)
Primary sequences of the GST-peptide substrates used in this study. All substrates
contain a phosphorylatable tyrosine residue (*). YP1 and YP2 contain canonical
Class I and Class II C-Src SH3 domain binding sequences. YA is a mutant of YP1 in
which the prolines have been substituted with alanine (underlined) and YL contains
the SH2:kinase linker sequence.
1996 S. Keenan et al. / FEBS Letters 589 (2015) 1995–2000study we performed the ﬁrst biochemical investigation of N2-Src
kinase since it was cloned in 1990 [7]. We show that similar to
N1-Src, N2-Src has a low afﬁnity for substrates containing canoni-
cal C-Src SH3 ligands. We also observed that N1-Src, and in partic-
ular N2-Src, have a lower threshold for activation by
auto-phosphorylation, likely due to weaker intramolecular interac-
tions between the SH3 domain and the SH2:kinase linker.
2. Materials and methods
2.1. Materials
Mouse monoclonal anti-phosphotyrosine (clone PY20) was
obtained from BD Bioscience (Oxford, UK). Rabbit polyclonalanti-Src pY527 and anti-Src pY416 were from Cell Signaling
Technologies (Hitchin, UK). Mouse anti-b-actin was from
Proteintech (Manchester, UK). Mouse anti-FLAG (clone M2),
anti-mouse and anti-rabbit HRP-conjugated secondary antibodies
and 2X SDS sample buffer were from Sigma (Poole, UK). Unless
stated otherwise, all other reagents were from Sigma.
2.2. Plasmids
The C-, N1- and N2-Src kinases and SH3 domains were cloned
by PCR from rat brain cDNA (Clontech, Oxford, UK). Plasmids for
expressing recombinant active D80C-Src, N1- or N2-Src in
Escherichia coli were prepared by inserting cDNA encoding
His-tagged rat Srcs lacking the ﬁrst 80 amino acids into
pGEX4T-1 (GE Healthcare, Little Chalfont, UK) containing the
human protein tyrosine phosphatase 1B (PTP1B) catalytic domain
with a 3C protease site at its C-terminus (Fig. 1A). FLAG-tagged
Src mammalian expression plasmids were prepared by
sub-cloning full length Src cDNA into pFLAG-N1 (pFLAG-N1 was
created by replacing the GFP sequence with a FLAG tag in
pEGFP-N1; Clontech), in which a GSGS linker was introduced at
the C-terminus prior to the tag. The GSGS linker has been
previously used to prepare C-Src-GFP and does not affect C-Src
activity [30]. Plasmids comprising a Src substrate and SH3 ligand
fused to GST (YA, YP1 and YP2) were prepared by ligating annealed
oligonucleotides encoding an ideal Src family kinase substrate
(AEEEIYGEF; [31]) into pGEX6P-1 (GE Healthcare; 50 BamHI and
30 EcoRI sites) and then SH3 docking sequences (Class I, YP1;
VSLARRPLPPLP and Class II, YP2; PPLPPRNRPRL; [32]) were ligated
into 30 SalI and 50 NotI sites (Fig. 1D). A plasmid encoding the cyto-
plasmic tail of synaptophysin fused to GST (pGEX-Syp-C-term) was
a kind gift from Prof Michael Cousin (University of Edinburgh).
2.3. Protein puriﬁcation
Recombinant His- and GST-fusion proteins were expressed and
puriﬁed according to a previously described protocol with minor
modiﬁcations for Src kinase expression [33]. For the production
of active Src kinases, BL21 E. coli cultures at an O.D600 = 1 were
induced with 0.5 mM IPTG and incubated at 18 C overnight, shak-
ing at 250 rpm. Following puriﬁcation with glutathione resin
(Genscript), the His-tagged kinases were cleaved from GST-PTP1B
by incubation with PreScission 3C protease (GE Healthcare) at
4 C overnight. The puriﬁed kinases were diluted 1:1 in kinase
storage buffer (50 mM Tris–HCl, pH 7.5, 10 mM NaCl, 0.05 mM
EDTA, 1 mM DTT, 10% glycerol, 1 mg/ml BSA, 0.05% NP-40), and
stored at 80 C. Approximately 0.5 mg pure kinase was obtained
from a 1 l culture of E. coli.
2.4. In vitro kinase assays
Phosphorylation reactions were prepared in kinase reaction
buffer (100 mM Tris, 10 mM MgCl2, pH 7.5) and initiated by the
addition of pre-warmed ATP (0.5 mM ﬁnal concentration) and
incubated at 30 C for the indicated times. Kinase and substrate
concentrations were varied as indicated in the ﬁgure legends.
Assays were terminated by transfer to ice and the immediate addi-
tion of 2X SDS sample buffer. Twenty percent of the reaction was
separated on a 15% SDS–PAGE gel and transferred to PVDF mem-
brane (Millipore, Croxley Green, UK). Substrate phosphotyrosine
content was determined by immunoblotting with mouse
anti-phosphotyrosine (1:1000) and anti-mouse-HRP (1:5000).
Immunoreactivity was visualised by incubation of immunoblots
with enhanced chemiluminescence reagent (Millipore) and expo-
sure to autoradiography ﬁlm (Santa Cruz, Dallas, TA). To ensure
equal protein loading, samples were stained with Coomassie gel
S. Keenan et al. / FEBS Letters 589 (2015) 1995–2000 1997stain to detect the substrates. Densitometric analysis of protein
bands on immunoblots was performed with ImageJ [34].
To measure enzyme kinetics, the samples representing each
substrate concentration phosphorylated by C-, N1- and N2-Src
kinases were separated on a single gel. To normalise densitometry
across multiple gels and produce curves across the full concentra-
tion range, a standard phosphorylated protein sample (8.3 lM YA
phosphorylated by C-Src) was included on each gel. The highest
value obtained by densitometry analysis of each curve was set to
1 and all other values were normalised accordingly. Due to the
non-quantitative measurement of V, Vmax was not determined.
Km was calculated from three independent experiments by ﬁtting
to Michaelis–Menton equations in the enzyme kinetics module of
SigmaPlot (Systat, Chicago, IL). Where appropriate, statistical
analyses of the data were performed with SigmaPlot software
using one- or two-way ANOVAwith post hoc pairwise comparisons
by Tukey tests.2.5. Cell culture, transfection and detection of Src expression
B104 rat neuroblastoma cells were cultured in DMEM
(Dulbecco’s minimal Eagle’s medium; Invitrogen, Paisley, UK) sup-
plemented with 10% foetal calf serum and 1% penicillin/strepto-
mycin (Invitrogen). For the analysis of Src-FLAG expression and
phosphorylation by immunoblotting, 3  104 cells were plated
per well of a 24 well plate and transfected 24 h after plating at a
ratio of 1 lg plasmid cDNA:2 ll EcoTransfect reagent according
to the manufacturer’s instructions (Oz Biosciences, Marseille,
France). Cells were lysed 48 h after transfection in SDS sample buf-
fer and analysed by immunoblotting with anti-FLAG (1:1000),
anti-Src-pY416 (1:1000), anti-Src-pY527 (1:1000), anti-
phosphotyrosine (1:1000), anti-b-actin (loading control; 1:50000) and
appropriate HRP-conjugated secondary antibodies (1:5000).3. Results and discussion
3.1. An in vitro kinase assay for SH3 domain substrate speciﬁcity
To perform a direct comparison between the substrate speciﬁci-
ties of C-, N1- and N2-Src, we developed an in vitro kinase assay
using recombinant truncated Src kinases (lacking the ﬁrst 80
amino acids) to phosphorylate peptide substrates fused to the
C-terminus of GST. The expression of active Src kinases in E. coli
is problematic, due to the toxicity of tyrosine phosphorylation in
bacteria that do not support this form of post-translational modiﬁ-
cation [35]. To overcome this issue we fused a cleavable tyrosine
phosphatase (PTP1B) catalytic domain to the N-terminus of the
kinase as previously reported (Fig. 1A; [36]). This modiﬁcation
yielded sufﬁcient pure active kinase to perform in vitro kinase
assays (Fig. 1B).
The substrates comprised an ideal Src kinase substrate
sequence (AEEEIYGEF; [31], fused to canonical proline rich SH3
ligand sequences (Fig. 1D; YP1 and YP2). A control sequence (YA)
was also included in which the prolines of YP1 were substituted
with alanine. In all the substrates there were at least ten amino
acids between the phosphorylatable tyrosine substrate and the
proline rich motif, which was adequate for SH3 domain docking
and phosphorylation by Hck and v-Src in a previous study [37].
To measure enzyme kinetics, experiments were ﬁrst conducted
with C-Src phosphorylation of YA to establish conditions where
phosphate incorporation was linear with time (Fig. 2). The rate of
the reaction (V) was determined by immunoblotting with an
anti-phosphotyrosine antibody, which was quantiﬁed by densito-
metry (Fig. 2). This assay therefore gave arbitrary values for Vmax,
but enabled numerical calculation of Km to assess the afﬁnity ofthe Src kinases for their substrates. Varying the kinase concentra-
tion (Fig. 2A) revealed that a concentration of 5 nM kinase would
be suitable for kinetic measurements. A timecourse of YA phospho-
rylation by C-, N1- or N2-Src revealed a lag in activity until approx-
imately 60–90 min, where phosphorylation of YA then increased
rapidly (Fig. 2B). This is consistent with the time taken for kinase
auto-phosphorylation (Fig. 4A), which is linked with activation of
the catalytic domain. The phosphorylation by all three kinases
was equivalent at 90 min and this reaction time was used for sub-
sequent kinetic experiments. Utilising these parameters whilst
varying the substrate concentration gave classical Michaelis–
Menten kinetics (Fig. 3A), with a Km of 28.7 ± 7.4 lM for phospho-
rylation of the YA substrate by C-Src, which compares favourably
with the previously observed Km of 33 lM for C-Src phosphorylat-
ing the free AEEEIYGEF peptide [31]. When we compared the phos-
phorylation of the YA substrate by C-, N1- and N2-Src, the Kms
were not signiﬁcantly different between the three kinases (Fig. 3D).
3.2. The N-Src SH3 domains have different ligand speciﬁcity to C-Src
To assess whether the N-Src SH3 domain speciﬁcity differs from
that of C-Src, phosphorylation of the YP1 and YP2 substrates was
investigated. In addition to an ideal Src phosphorylation site, YP1
and YP2 contain Class I and Class II PxxP motifs respectively,
deﬁned by a positively charged arginine residue before (Class I)
or after (Class II) the PxxP motif (Fig. 1D). It was previously shown
that peptides encoding an SH3 ligand C-terminal to a tyrosine
phosphorylation site lowered the Km, but did not affect the Vmax,
of v-Src [37]. The presence of a Class I or Class II (Fig. 3A) ligand
C-terminal to the kinase substrate sequence signiﬁcantly
enhanced phosphorylation by C-Src with Kms of 4.3 ± 1.0 lM and
6.1 ± 1.2 lM for YP1 and YP2 respectively, compared to
28.7 ± 7.4 lM for YA (Fig. 3D).
In stark contrast to C-Src, the Kms for the phosphorylation of
YP1 and YP2 by N1- (Fig. 3B) and N2-Src (Fig. 3C) were not signif-
icantly different from YA (Fig. 3D). These are the ﬁrst data to
demonstrate that SH3 domain speciﬁcity affects N-Src afﬁnity for
a substrate in a kinase assay, and support several immunoprecipi-
tation, pulldown or in vitro binding assays showing differences
between the C- and N1-Src SH3 domains. Furthermore, NMR
studies of the C-Src SH3 domain have shown that the n-Src loop,
the site of N-Src splicing, contacts basic residues up- or down-
stream of the core PxxP motif of Class I or Class II SH3 ligands
respectively [14,38]. These studies provide a structural hypothesis
for how splicing alters SH3 speciﬁcity, suggesting that speciﬁc
ligands for the N1- and N2-SH3 domains might have alternative
ﬂanking residues outside the PxxP motif.
3.3. High auto-phosphorylation of N2-Src in vitro and in cells
Auto-phosphorylation of Y416 (based on the amino acid num-
bering of chicken C-Src and used from here onwards for C, N1
and N2-Src) is a key step in the activation of the Src kinase domain
and it has been previously reported that N1-Src has a higher con-
stitutive activity than C-Src [26,27]. In our in vitro kinase assays
we were unable to detect kinase auto-phosphorylation due to the
low kinase concentration (5 nM). Assays were therefore performed
in which 200 nM C-, N1 or N2-Src was incubated with ATP at 30 C
and samples removed at 0, 1 and 3 h prior to analysis of pY416
immunoreactivity. C-Src phosphorylation was barely detectable
at 3 h, even with a long exposure of the immunoblot, whereas
phosphorylation of the neuronal Srcs was readily detectable, with
N2-Src approximately 4-fold more phosphorylated than N1-Src at
3 h (Fig. 4A). Comparing this timecourse with that of YA in Fig. 2A
suggests that in vitro, despite a high auto-phosphorylation activity,
phosphorylation of an ideal substrate is not signiﬁcantly greater.
Fig. 2. Characterisation of an in vitro kinase assay for Src. All kinase assays were
carried out at 30 C, initiated by the addition of 0.5 mM ATP and halted by transfer
to ice and the immediate addition of SDS sample buffer. (A) 25 lM YA (an ideal Src
substrate peptide fused to GST, see Fig. 1D) was incubated with the indicated
concentrations of His-D80C-Src for 90 min. Reactions were separated in duplicate
by SDS–PAGE, and either stained with Coomassie (bottom panel) or transferred to
PVDF membrane and immunoblotted with an anti-phosphotyrosine antibody (pY;
top panel). Values for Vwere obtained from densitometry of the pY immunoreactive
bands with ImageJ, normalised to the amount of Coomassie stained YA and plotted
in arbitrary units against enzyme concentration. (B) 25 lM YA was incubated with
5 nM C-, N1- or N2-Src for the indicated times and the samples treated and
analysed as described in (A). All data are plotted as mean ± S.E.M., from n = 3
independent experiments.
Fig. 3. Canonical Class I and Class II proline rich motifs enhance phosphorylation of
an ideal substrate by C-Src but not the N-Srcs. Phosphorylation of substrates
containing Class I (YP1) or Class II (YP2) proline rich motifs, at the indicated
concentrations, by 5 nM HisD80C- (A), N1- (B) or N2-Src (C) was performed for
90 min. The initial rate (V) for each reaction was calculated by densitometry (by
ImageJ) of anti-phosphotyrosine immunoblots (normalised as described in Fig. 1)
and plotted against substrate concentration. Curve ﬁtting to calculate Michaelis–
Menten parameters was performed using SigmaPlot. (D) Comparison of the Km of
YA, YP1 and YP2 substrate phosphorylation by C-, N1- and N2-Src. All data are
plotted as mean ± S.E.M., from n = 3 independent experiments. Statistical signiﬁ-
cance was determined by two way ANOVA, *P < 0.05.
1998 S. Keenan et al. / FEBS Letters 589 (2015) 1995–2000There are other reports where pY416 does not directly correlate
with activity, for example, v-Src phosphorylates substrates
10-fold more than C-Src but its auto-phosphorylation is only
between 1 and 2-fold higher than C-Src [39].
We next determined the kinases’ phosphorylation status in
cells, where they are subject to physiological regulation. In
addition to detecting pY416, phosphorylation of Y527 was also
analysed. Y527 phosphorylation at the C-terminus of Src by Csk
promotes intramolecular association with the SH2 domain and is
indicative of the inactive form of the kinase. Cell lysates from
B104 rat neuroblastoma cells transfected with FLAG-tagged
C-, N1- or N2-Src were analysed by immunoblotting with
anti-pY416 and anti-pY527 antibodies. We observed no pY416
signal in untransfected cells and a weak signal in cells transfected
with C-Src, however, pY527 immunoreactivity was readily
detected for C-Src (Fig. 4B). Therefore, it is likely that C-Src
expressed in the cell is predominantly in an inactive conformation
as previously reported [40]. In contrast, strong pY416 immunore-
activity was observed in cells transfected with N1- or N2-Src in
bands that aligned with those in an anti-FLAG immunoblot
(Fig. 4B). An additional intense band was observed migrating above
N2-Src, that might represent activation of another endogenous
SFK. Surprisingly, N1-Src had a pY527 signal comparable to C-Src
while the signal for N2-Src was greatly reduced (Fig. 4B). The
neuronal Srcs therefore have a higher basal level of
auto-phosphorylation than C-Src, inferring a higher basal level of
kinase activity. The enhanced auto-phosphorylation of N1-Src
above that of C-Src has been previously reported [8,26,27] and
we now show that N2-Src has even greater activity, both in vitro
and in cells.
To assess whether transfection of the apparently highly active
N-Srcs resulted in increased cellular substrate phosphorylation,we probed the same lysates for total phosphotyrosine content.
This revealed that the major phosphorylated proteins within the
cells are the neuronal Srcs themselves (Fig. 4B), presumably at
pY416 and pY527. In addition, readily detectable phosphotyrosine
immunoreactivity of other cellular proteins was observed for
N2-Src transfected cells and faint bands were observed for
N1-Src. Thus, the extent of basal phosphorylation of substrate pro-
teins in cells for C-, N1- and N2-Src correlates with their
auto-phosphorylation activity in cells and perhaps we would
observe a similar correlation in vitro with bona ﬁde N-Src
substrates.
Fig. 4. N-Srcs have enhanced levels of Y416 auto-phosphorylation in vitro and in
cells compared to C-Src. (A) 200 nMHisD80C-, N1- or N2-Src was incubated at 30 C
with 0.5 mM ATP for 0, 1 or 3 h and processed for immunoblotting with anti-pY416
and anti-His (loading control). pY416 immunoreactivity was obtained by densit-
ometry with ImageJ and normalised to the anti-His signal. Data are plotted as
mean ± S.E.M., from n = 3 independent experiments. (B) B104 cells were transfected
with plasmids encoding FLAG-tag alone (control) or C-terminal FLAG-tagged full
length C-, N1- or N2-Src, and the lysed after 48 h. The lysates were analysed by
immunoblotting with anti-FLAG (FLAG), anti-phosphotyrosine (pY), anti-pY416
(active Src), anti-pY527 (inactive Src) and b-actin (loading control). The immuno-
blots are representative of at least three independent experiments.
Fig. 5. The Src SH2:kinase linker sequence and the synaptic vesicle protein
synaptophysin are poor substrates for the N-Srcs compared to C-Src.
Phosphorylation of a substrate containing the Src SH2:kinase linker, at the indicated
concentrations, by 5 nM HisD80C-, N1- or N2-Src was performed for 90 min. (A)
The initial rate (V) for each reaction was calculated by densitometry (by ImageJ) of
anti-phosphotyrosine immunoblots and plotted against substrate concentration.
Curve ﬁtting to generate Michaelis–Menten parameters was performed using the
kinetics module in SigmaPlot. (B) Comparison of the Km of substrate phosphory-
lation. All data are plotted as mean ± S.E.M., from n = 3 independent experiments.
Statistical signiﬁcance was determined by one way ANOVA, *P < 0.05. (C) 10 lM
GST-synaptophysin C-terminus (SYP) was incubated at 30 C with 66 nM HisD80C-,
N1- or N2-Src and 0.5 mM ATP for 3 h. Reactions were separated in duplicate by
SDS–PAGE, and either stained with Coomassie (SYP) or transferred to PVDF
membrane and immunoblotted with anti-phosphotyrosine (pY) and anti-His
(His6). The images are representative of at least three independent experiments.
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The enhanced auto-phosphorylation activity of the N-Srcs is
reminiscent of mutants of C-Src that reduce intramolecular inter-
actions. The availability of Y416 in the kinase domain activation
loop is tightly regulated by two intramolecular associations: SH2
binding to a C-terminal phosphotyrosine (pY527) and SH3 binding
to the SH2:kinase linker. Evidence is accumulating to suggest that
the disruption of either of these interactions, akin to an ‘OR-gate’
switch, is sufﬁcient to permit auto-phosphorylation on Y416 for
full activity [29,41]. We hypothesised that the increased cellular
basal activity of the N-Srcs was due to a perturbation of the
intramolecular interaction between the SH3 domain and the
SH2:kinase linker, which normally constrains SFK kinase activity.
The function of the linker (248SKPQTQGLAKDA) was ﬁrst delineated
by deletions and mutations in the SH3 domains of Src and Hck that
increased kinase activity [42,43]. To investigate the afﬁnity of the
N-Src SH3 domains for the linker sequence, we assayed the
phosphorylation of a GST-peptide substrate (Fig. 5A), in which
the linker sequence was inserted next to the ideal substrate motif
(YL; Fig. 1D). The Km for C-Src phosphorylation of YL was
5.2 ± 1.1 lM (Fig. 5B), similar to the Km for the phosphorylation
of the ideal substrates YP1 and YP2 (Fig. 3D). This was somewhat
surprising, considering the linker does not contain a canonicalPxxP motif. The Km for YL phosphorylation by both N1- and
N2-Src was signiﬁcantly decreased to 10.7 ± 1.5 and
14.6 ± 2.1 lM respectively (Fig. 5B). This implies that the N-Src
SH3 domains bind more weakly to the linker sequence, due to
steric hindrance by the n-Src loop. In the context of the full length
kinase, a reduction in this intramolecular interaction could explain
why these kinases are more susceptible to auto-phosphorylation.
3.5. Differential speciﬁcity of the Srcs for a neuronal C-Src substrate
Having observed differential speciﬁcity of the N-Srcs for ideal
SH3 ligands, we investigated the phosphorylation of an established
in vivo C-Src substrate in brain, synaptophysin, a synaptic vesicle
membrane tyrosine phosphoprotein [44,45]. We conﬁrmed that
2000 S. Keenan et al. / FEBS Letters 589 (2015) 1995–2000the cytoplasmic C-terminus of synaptophysin is an excellent sub-
strate for C-Src (Fig. 5C), but surprisingly observed little phospho-
rylation of the protein by N1- and N2-Src. This experiment
reafﬁrms that SH3 domain speciﬁcity overrides the
auto-phosphorylation activity of the N-Srcs for determining the
extent of phosphorylation of their substrates.
Taken together, we have shown that in cells and in vitro, N2-Src
has a high auto-phosphorylation activity, likely driven by weak
intramolecular interactions. The N-Src SH3s have a weak afﬁnity
for peptide substrates containing Class I and Class II C-Src SH3
ligands and future work is required to establish the in vivo sub-
strates of the N-Srcs and the structural basis of high afﬁnity bind-
ing to the N-Src SH3 domains. Such studies could facilitate the
development of isoform-speciﬁc inhibitors that can distinguish
the kinases by disrupting SH3 ligand binding.
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